REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Instituto Nacional de Cancerologia (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Instituto Nacional de Cancerologia Profile Updated: November 20, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Instituto Nacional de Cancerologia is based in Colombia. The head office is in Bogota D.C.. The company operates in the Ambulatory Health Care Services industry. It was first established on December 15, 2014. In its most recent financial highlights, the company reported a net sales revenue increase of 26.82% in 2023. Its total assets grew by 48.17% over the same period. The net profit margin of Instituto Nacional de Cancerologia increased by 36.06% in 2023.

Headquarters
Calle 1 9 - 85
Bogota D.C.; Bogota D.C; Postal Code: 111511

Contact Details: Purchase the Instituto Nacional de Cancerologia report to view the information.

Website: http://www.cancer.gov.co

Basic Information
Outstanding Shares:
Purchase the Instituto Nacional de Cancerologia report to view the information.
Incorporation Date:
December 15, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Purchase this report to view the information.
Head of Internal Control
Company Performance
Financial values in the chart are available after Instituto Nacional de Cancerologia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
26.82%▲
Total operating revenue
41.99%▲
Operating profit (EBIT)
N/A
EBITDA
468.32%▲
Net Profit (Loss) for the Period
1125.1%▲
Total assets
48.17%▲
Total equity
39.95%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
36.06%▲
Return on Equity (ROE)
25.28%▲
Quick Ratio
-4.72%▼
Cash Ratio
-1.78%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo